Stress Reduction and Anxiety: Effects on the Function and Structure of the Brain
2 other identifiers
interventional
29
1 country
1
Brief Summary
The aim of the study is to test whether Generalized Anxiety Disorder (GAD) patients that participate in a Stress Reduction Intervention show a brain activation pattern (assessed by MRI) indicative of improved emotion regulation compared to an active control intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2010
CompletedFirst Submitted
Initial submission to the registry
May 19, 2010
CompletedFirst Posted
Study publicly available on registry
May 21, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2011
CompletedMay 7, 2012
May 1, 2012
11 months
May 19, 2010
May 4, 2012
Conditions
Outcome Measures
Primary Outcomes (2)
brain activation and structure as assessed by MRI
BOLD functional MRI and structural MRI
Day 1 (within two weeks before the intervention)
brain activation and structure as assessed by MRI
BOLD functional MRI and structural MRI
Day 2 (within two weeks after the intervention)
Study Arms (2)
Stress Reduction Intervention
EXPERIMENTALStress Reduction Intervention
Active Control Condition
ACTIVE COMPARATORInterventions
eight week group program, plus daily homework practice
weekly group meetings for eight weeks, plus daily homework practice
Eligibility Criteria
You may qualify if:
- participation in the study 'Stress Reduction Techniques and Anxiety: Therapeutic and Neuroendocrine Effects" by Dr. Elizabeth Hoge
You may not qualify if:
- metallic implants
- left handed
- epileptic seizures
- head trauma
- weight over 350 pounds
- claustrophobia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Massachusetts General Hospitallead
- European Commissioncollaborator
Study Sites (1)
Massachusetts General Hospital
Charlestown, Massachusetts, 02129, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sara W Lazar, PhD
Massachusetts General Hospital
- PRINCIPAL INVESTIGATOR
Britta K Holzel, PhD
Massachusetts General Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Fellow
Study Record Dates
First Submitted
May 19, 2010
First Posted
May 21, 2010
Study Start
May 1, 2010
Primary Completion
April 1, 2011
Study Completion
April 1, 2011
Last Updated
May 7, 2012
Record last verified: 2012-05